Literature DB >> 12923612

Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.

A Newman-Tancredi1, J-M Rivet, D Cussac, M Touzard, C Chaput, L Marini, M J Millan.   

Abstract

This study employed [(35)S]guanosine 5'- O-(3-thiotriphosphate) ([(35)S]GTPgammaS) binding to compare the actions of antipsychotic agents known to stimulate cloned, human 5-HT(1A) receptors with those of reference agonists at postsynaptic 5-HT(1A) receptors. In rat hippocampal membranes, the following order of efficacy was observed (maximum efficacy, E(max), values relative to 5-HT=100): (+)8-OH-DPAT (85), flesinoxan (62), eltoprazine (60), S14506 (59), S16924 (48), buspirone (41), S15535 (22), clozapine (22), ziprasidone (21), pindolol (7), p-MPPI (0), WAY100,635 (0), spiperone (0). Despite differences in species and tissue source, the efficacy and potency (pEC(50)) of agonists (with the exception of clozapine) correlated well with those determined previously at human 5-HT(1A) receptors expressed in Chinese hamster ovary (CHO) cells. In contrast, clozapine was more potent at hippocampal membranes. The selective antagonists p-MPPI and WAY100,635 abolished stimulation of binding by (+)8-OH-DPAT, clozapine and S16924 (p-MPPI), indicating that these actions were mediated specifically by 5-HT(1A) receptors. Clozapine and S16924 also attenuated 5-HT- and (+)8-OH-DPAT-stimulated [(35)S]GTPgammaS binding, consistent with partial agonist properties. In [(35)S]GTPgammaS autoradiographic studies, 5-HT-induced stimulation, mediated through 5-HT(1A) receptors, was more potent in the septum (pEC(50) approximately 6.5) than in the dentate gyrus of the hippocampus (pEC(50) approximately 5) suggesting potential differences in coupling efficiency or G protein expression. Though clozapine (30 and 100 microM) did not enhance [(35)S]GTPgammaS labelling in any structure, S16924 (10 micro M) modestly increased [(35)S]GTPgammaS labelling in the dentate gyrus. On the other hand, both these antipsychotic agents attenuated 5-HT (10 microM)-stimulated [(35)S]GTPgammaS binding in the dentate gyrus and septum. In conclusion, clozapine, S16924 and ziprasidone act as partial agonists for G protein activation at postsynaptic 5-HT(1A) receptors in the hippocampus. These data support a role of postsynaptic 5-HT(1A) receptors in the functional profiles of certain antipsychotic agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923612     DOI: 10.1007/s00210-003-0788-2

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  54 in total

Review 1.  5-HT system and cognition.

Authors:  A Meneses
Journal:  Neurosci Biobehav Rev       Date:  1999-12       Impact factor: 8.989

Review 2.  An overview on functional receptor autoradiography using [35S]GTPgammaS.

Authors:  J Sóvágó; D S Dupuis; B Gulyás; H Hall
Journal:  Brain Res Brain Res Rev       Date:  2001-12

3.  Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.

Authors:  Didier Cussac; Delphine Duqueyroix; Adrian Newman-Tancredi; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2002-04-30       Impact factor: 4.530

Review 4.  The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis.

Authors:  W K Kroeze; B L Roth
Journal:  Biol Psychiatry       Date:  1998-12-01       Impact factor: 13.382

5.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.

Authors:  Cornelius Gross; Xiaoxi Zhuang; Kimberly Stark; Sylvie Ramboz; Ronald Oosting; Lynn Kirby; Luca Santarelli; Sheryl Beck; René Hen
Journal:  Nature       Date:  2002-03-28       Impact factor: 49.962

6.  [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.

Authors:  P W Burnet; S L Eastwood; P J Harrison
Journal:  Neurochem Int       Date:  1997-06       Impact factor: 3.921

7.  Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study.

Authors:  Yuan-Hwa Chou; Christer Halldin; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

8.  Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.

Authors:  A Newman-Tancredi; L Verrièle; M Touzard; M J Millan
Journal:  Eur J Pharmacol       Date:  2001-10-05       Impact factor: 4.432

9.  S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol.

Authors:  M J Millan; M Brocco; A Gobert; R Schreiber; A Dekeyne
Journal:  J Pharmacol Exp Ther       Date:  1999-03       Impact factor: 4.030

Review 10.  Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration.

Authors:  Julie G Hensler
Journal:  Life Sci       Date:  2003-02-28       Impact factor: 5.037

View more
  5 in total

Review 1.  Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors.

Authors:  Philip G Strange
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile.

Authors:  A Newman-Tancredi; M-B Assié; J-C Martel; C Cosi; L Bruins Slot; C Palmier; I Rauly-Lestienne; F Colpaert; B Vacher; D Cussac
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

3.  Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia.

Authors:  Xue Sun; Hong-yan Gou; Fei Li; Guan-yi Lu; Rui Song; Ri-fang Yang; Ning Wu; Rui-bin Su; Bin Cong; Jin Li
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

4.  Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist.

Authors:  A Newman-Tancredi; J-C Martel; M-B Assié; J Buritova; E Lauressergues; C Cosi; P Heusler; L Bruins Slot; F C Colpaert; B Vacher; D Cussac
Journal:  Br J Pharmacol       Date:  2009-01-12       Impact factor: 8.739

5.  Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists.

Authors:  Ana P Abdala; John M Bissonnette; Adrian Newman-Tancredi
Journal:  Front Physiol       Date:  2014-05-30       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.